GENVOYA 150MG/150MG/200MG/10 MG TBL FLM 30

Show dosage form

What is the maximum co-payment for GENVOYA?

If the insurance company contributes, the maximum co-payment is 302,97 Kč. The maximum pharmacy price is 16 947,60 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.

Does the medicine have reimbursement from public health insurance?

A medicine whose use is, in the public interest, appropriate to concentrate in specialized facilities pursuant to Section 15(10) of the Public Health Insurance Act. The medicine is reimbursed as ZÚLP and only from a facility that has a contract with the health insurer.

Does GENVOYA have a counted co-payment set?

No, this medicine has no counted co-payment.

How much does the insurance company pay for one dispensed reimbursed pack?

16 644,63 Kč.

Does the insurance company pay a higher amount in some cases?

No, the medicine has no increased reimbursement.

Does the medicine have an indication restriction?

Fixní kombinace elvitegraviru, kobicistatu, emtricitabinu a tenofovir-alafenamid-fumarátu je hrazena v léčbě infekce virem lidské imunodeficience typu 1 (HIV-1) u dospělých pacientů:
1) dosud neléčených antiretrovirotiky bez známých mutací spojených s rezistencí na kterékoliv ze tří antiretrovirotik obsažených v přípravku;
2) již léčených antiretrovirovými přípravky bez známek selhávání dosavadní léčby.

Is it available without a medical prescription?

No, the medicine cannot be obtained without a prescription.

Which medical specialist may prescribe GENVOYA?

Prescription is not conditional on a medical specialization.

What is the composition of GENVOYA?

Elvitegravir (150 mg), kobicistat (150 mg), emtricitabin (200 mg), tenofovir-alafenamid-fumarát, tenofovir-alafenamid (10 mg), monohydrát laktosy, neznámá látka s kódem 3755, sodná sůl kroskarmelosy, neznámá látka s kódem 4336, oxid křemičitý, natrium-lauryl-sulfát, magnesium-stearát, polyvinylalkohol, oxid titaničitý, neznámá látka s kódem 4077, ointmentek, neznámá látka s kódem 2609, žlutý oxid železitý. More information about the composition can be found in the SPC, section 6.1.

Where can I find information about correct use of the medicine?

Which medicines are similar to GENVOYA?

The medicine belongs to ATC group J05AR18 – EMTRICITABIN, TENOFOVIR-ALAFENAMID, ELVITEGRAVIR A KOBICISTAT. Medicines with the same active substance can be found here.

Who manufactures GENVOYA?

Gilead Sciences Ireland UC, Carrigtohill (IRL)

Is the medicine in shortage?

The latest report from the manufacturer is from 2. 10. 2016. Production has been officially started as of 16. 9. 2016.

What is the unique code for GENVOYA?

The medicine has code 0209033. Code details can be found here.

How many packs of GENVOYA were previously dispensed on prescriptions in Czechia?

Show prescription medicine consumption

How many packs of GENVOYA were previously dispensed on request forms in Czechia?

Show request-form medicine consumption

PODOBNÉ PŘÍPRAVKY:

The page was last updated on 03. 05. 2026

SIMILAR MEDICINES: